Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1985 2
1986 1
1987 3
1988 4
1989 3
1991 3
1992 8
1993 4
1994 3
1995 5
1996 4
1997 2
1998 1
2003 2
2004 1
2005 2
2006 4
2008 1
2012 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.
Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, Blättler WA, Lambert JM, Chari RV, Lutz RJ, Wong WL, Jacobson FS, Koeppen H, Schwall RH, Kenkare-Mitra SR, Spencer SD, Sliwkowski MX. Lewis Phillips GD, et al. Among authors: blattler wa. Cancer Res. 2008 Nov 15;68(22):9280-90. doi: 10.1158/0008-5472.CAN-08-1776. Cancer Res. 2008. PMID: 19010901
Developing drug molecules for therapy with carbon monoxide.
Romão CC, Blättler WA, Seixas JD, Bernardes GJ. Romão CC, et al. Among authors: blattler wa. Chem Soc Rev. 2012 May 7;41(9):3571-83. doi: 10.1039/c2cs15317c. Epub 2012 Feb 20. Chem Soc Rev. 2012. PMID: 22349541 Review.
Semisynthetic maytansine analogues for the targeted treatment of cancer.
Widdison WC, Wilhelm SD, Cavanagh EE, Whiteman KR, Leece BA, Kovtun Y, Goldmacher VS, Xie H, Steeves RM, Lutz RJ, Zhao R, Wang L, Blättler WA, Chari RV. Widdison WC, et al. Among authors: blattler wa. J Med Chem. 2006 Jul 13;49(14):4392-408. doi: 10.1021/jm060319f. J Med Chem. 2006. PMID: 16821799
55 results